3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is ever more attracting clinical focus due to initial evidence suggesting distinct pharmacological actions. Current studies indicate that https://www.pinterest.com/pin/1140888518124046392/